Attached files
| file | filename |
|---|---|
| EX-31 - EXHIBIT 31 - ORE PHARMACEUTICAL HOLDINGS INC. | a6099028ex31.htm |
| EX-3.1 - EXHIBIT 3.1 - ORE PHARMACEUTICAL HOLDINGS INC. | a6099028ex3_1.htm |
| EX-10.118 - EXHIBIT 10.118 - ORE PHARMACEUTICAL HOLDINGS INC. | a6099028ex10_118.htm |
| EX-10.92C - EXHIBIT 10.92C - ORE PHARMACEUTICAL HOLDINGS INC. | a6099028ex10_92c.htm |
| 10-Q - ORE PHARMACEUTICAL HOLDINGS INC. - ORE PHARMACEUTICAL HOLDINGS INC. | a6099028.htm |
Exhibit
32
CERTIFICATIONS
PURSUANT TO
18
U.S.C. SECTION 1350
AS
ADOPTED PURSUANT TO
SECTION
906 OF THE SARBANES-OXLEY ACT OF 2002
Each of
the undersigned hereby certifies, in his capacity as an officer of Ore
Pharmaceutical Holdings Inc. (the “Company”), for purposes of 18 U.S.C. Section
1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that
to such officer’s knowledge:
|
·
|
The
Quarterly Report of the Company on Form 10-Q for the quarterly period
ended September 30, 2009 fully complies with the requirements of Section
13(a) or 15(d) of the Securities Exchange Act of 1934;
and
|
|
·
|
The
information contained in such report fairly presents, in all material
respects, the financial condition and results of operations of the
Company.
|
|
Date:
|
November
13, 2009
|
By:
|
/s/ Mark J.
Gabrielson
|
|
Mark
J. Gabrielson
|
|||
|
President
and Chief Executive Officer
|
|||
|
(Principal
Executive Officer)
|
|||
|
Date:
|
November
13, 2009
|
By:
|
/s/ Benjamin L.
Palleiko
|
|
Benjamin
L. Palleiko
|
|||
|
Senior
Vice President and
|
|||
|
Chief
Financial Officer
|
|||
|
(Principal
Financial and Accounting
Officer)
|
A signed
original of this written statement required by Section 906 has been provided to
the Company and will be retained by the Company and furnished to the Securities
and Exchange Commission or its staff upon request.